Everything You Need To Know About Multiple Sclerosis
- 6 Likes
- 2 Comments
The 2018 campaign is called #bringinuscloser and the theme is ‘research’.
Sanofi Genzyme, the specialty care global business unit of Sanofi, and Multiple Sclerosis Society of India (MSSI) have joined hands to raise awareness and to provide better treatment solutions for the 130,000 people living with Multiple Sclerosis (MS) in India. Multiple Sclerosis is an autoimmune, debilitating disease of the nervous system that affects the spinal cord and brain. In multiple sclerosis, there is progressive damage to the sheath that protects nerve cells, impairing communication between the brain and the nervous system. Symptoms of Multiple Sclerosis vary from one person to the next, however, there are a few common signs. Which include:
- Weakness and numbness in the limbs.
- Poor vision.
- Tingling and pain in parts of the body.
- Unsteady gait.
- Lack of coordination.
- Fatigue or slurred speech.
Sanofi Genzyme and MSSI are working together to ensure that people affected with multiple sclerosis can continue to live fuller lives through support programs that enhance their quality of life. These programs will help bring the Multiple Sclerosis (MS) community together to share stories and raise awareness about the condition. The eight MSSI chapters in - Delhi, Mumbai, Bengaluru, Chennai, Hyderabad, Kolkata, Indore and Pune, along with Sanofi Genzyme are rolling out this year’s campaign #bringinguscloser, through various awareness programs such as symposiums, MS camps, MS walks, medical seminars, photo exhibitions, and laughter & music therapy sessions.
“At Sanofi, one of our priorities is to empower people with multiple sclerosis and improve their quality of life. Sanofi Genzyme is proud to support initiatives, including educational projects, and provide information and resources to raise awareness of multiple sclerosis in India. In line with that objective, we are in the process of introducing new and effective treatment options in India that would help in the management of this debilitating disease,” said N. Rajaram, Managing Director of Sanofi India. Through its partnership with the MSSI in India, Sanofi Genzyme is playing a critical role in enabling and empowering the lives of people with multiple sclerosis. Globally, Sanofi Genzyme is continuously working to advance multiple sclerosis treatment and care with therapies, a portfolio of research and development-stage programs, and MS research collaborations. Viresh Oberoi, Honorary President, Multiple Sclerosis Society of India (MSSI) commented, “During the month of May, every year, around the World, an added focus is brought to spread solidarity amongst our members (those afflicted with multiple sclerosis, their caregivers and family members, doctors, nurses, well-wishers) and, to reach out to those who are not currently our members to share with them how we can help them cope with this affliction. Even today we do not know with certainty what causes multiple sclerosis and how we can eliminate it. The theme of this year’s ‘celebration’ of World MS Day is ‘Bringing us closer - An objective, which I am sure which will make us all stronger and will provide hope for the future.”
World MS Day is officially marked on the last Wednesday of May, each year since 2009. This year it is being commemorated on 30th of May. The 2018 campaign is called #bringinuscloser and the theme is ‘research’.